FindTrial
Sign In

Exploring differences in blood TCR gene expression in patients with hormone-effective and ineffective inflammatory pseudotumors

Exploring differences in blood TCR gene expression in patients with hormone-effective and ineffective inflammatory pseudotumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300076795
Enrollment
Unknown
Registered
2023-10-18
Start date
2022-02-22
Completion date
Unknown
Last updated
2023-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory pseudotumors

Interventions

Hormone effective inflammatory pseudotumor group:None
Hormone ineffective inflammatory pseudotumor group:None

Sponsors

Eye Hospital, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 71 Years

Inclusion criteria

Inclusion criteria: Patients with a diagnosis of "inflammatory pseudotumor of the orbit" who have not been treated in the last month.

Exclusion criteria

Exclusion criteria: Patients with other serious systemic diseases, autoimmune diseases; acute and chronic inflammatory lesions in the orbit due to orbital inflammatory lesions with clear local causes such as intraorbital bacterial or fungal infections after ocular trauma; orbital neoplastic lesions such as adenoid cystic carcinoma, lymphoma, etc.; patients with recurrence of orbital inflammatory pseudotumor.

Design outcomes

Primary

MeasureTime frame
TCR sequencing data of blood samples;—

Countries

China

Contacts

Public ContactWang Min

Eye Hospital, Wenzhou Medical University

18068520016@eye.ac.cn+86 180 6852 0016

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026